LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 2 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 2. - Dataset (ID:20310)

Filter results: >>>>
Cell Small Molecule Small Mol Concentration (uM) Time Point (hr) Total Cell Count Before Treatment Total Cell Count After Treatment Total Control Cell Count Relative Cell Count Normalized Growth Rate Inhibition Value Assay Plate Assay Well
MCF 10A-H2B-mCherry Trametinib
1
5.03 17.25 1 273 0.0037 -0.5106
MN20160310_N02
I10
MCF 10A-H2B-mCherry Trametinib
1
5.03 17.25 949 273 3.4716 1.7330
MN20160310_N02
I10
MCF 10A-H2B-mCherry Trametinib
1
7.01 17.25 1 389 0.0026 -0.4692
MN20160310_N02
I09
MCF 10A-H2B-mCherry Trametinib
1
7.01 17.25 1004 389 2.5777 1.4688
MN20160310_N02
I09
MCF 10A-H2B-mCherry Trametinib
1
7.01 17.25 1 389 0.0026 -0.4692
MN20160310_N02
I10
MCF 10A-H2B-mCherry Trametinib
1
7.01 17.25 1046 389 2.6855 1.4914
MN20160310_N02
I10
MCF 10A-H2B-mCherry Trametinib
1
8.98 17.25 1 445 0.0022 -0.4552
MN20160310_N02
I09
MCF 10A-H2B-mCherry Trametinib
1
8.98 17.25 1085 445 2.4378 1.4186
MN20160310_N02
I09
MCF 10A-H2B-mCherry Trametinib
1
8.98 17.25 1 445 0.0022 -0.4552
MN20160310_N02
I10
MCF 10A-H2B-mCherry Trametinib
1
8.98 17.25 1095 445 2.4603 1.4233
MN20160310_N02
I10
MCF 10A-H2B-mCherry Trametinib
1
10.95 17.25 1 471 0.0021 -0.4494
MN20160310_N02
I09
MCF 10A-H2B-mCherry Trametinib
1
10.95 17.25 1109 471 2.3517 1.3925
MN20160310_N02
I09
MCF 10A-H2B-mCherry Trametinib
1
10.95 17.25 1 471 0.0021 -0.4494
MN20160310_N02
I10
MCF 10A-H2B-mCherry Trametinib
1
10.95 17.25 1131 471 2.3984 1.4023
MN20160310_N02
I10
MCF 10A-H2B-mCherry Trametinib
1
12.91 17.25 1 494 0.0020 -0.4446
MN20160310_N02
I09
MCF 10A-H2B-mCherry Trametinib
1
12.91 17.25 1138 494 2.2997 1.3753
MN20160310_N02
I09
MCF 10A-H2B-mCherry Trametinib
1
12.91 17.25 2 494 0.0040 -0.3592
MN20160310_N02
I10
MCF 10A-H2B-mCherry Trametinib
1
12.91 17.25 1156 494 2.3360 1.3830
MN20160310_N02
I10
MCF 10A-H2B-mCherry Trametinib
1
14.88 17.25 1 534 0.0019 -0.4373
MN20160310_N02
I09
MCF 10A-H2B-mCherry Trametinib
1
14.88 17.25 1172 534 2.1930 1.3436
MN20160310_N02
I09
MCF 10A-H2B-mCherry Trametinib
1
14.88 17.25 8 534 0.0150 -0.1437
MN20160310_N02
I10
MCF 10A-H2B-mCherry Trametinib
1
14.88 17.25 1210 534 2.2641 1.3587
MN20160310_N02
I10
MCF 10A-H2B-mCherry Trametinib
1
16.85 17.25 33 655 0.0503 0.1316
MN20160310_N02
I09
MCF 10A-H2B-mCherry Trametinib
1
16.85 17.25 1218 655 1.8579 1.2506
MN20160310_N02
I09
MCF 10A-H2B-mCherry Trametinib
1
16.85 17.25 68 655 0.1037 0.2987
MN20160310_N02
I10